MediPines Gas Exchange Monitor Cleared by FDA for Comprehensive Lung Function Analysis

MediPines, a company based in California’s Orange County, obtained FDA clearance for its MediPines Gas Exchange Monitor. The device is used to measure and monitor a variety of respiratory parameters and indices of patients presenting with lung conditions.

It can help to quickly triage patients and make decision making easier by providing parameters such as PIO2, PETCO2, and Oxygen Deficit. Even the pulse rate and oxygen saturation of blood (SpO2) can be obtained by the patient simply breathing into a mouthpiece.

A comprehensive test takes only a few minutes and it is non-invasive and can be performed at the point of care. The device is portable, and so can be used in mass casualty situations affecting people’s lungs.

Here is the full list of the real-time respiratory parameters and calculated indices that the MediPines Gas Exchange Monitor can provide, according to the company:

  • Functional Oxygen Saturation (SpO2%) – The percentage of oxygen saturated hemoglobin relative to total hemoglobin in arterial blood
  • Pulse Rate (PR) – The number of times the heart beats per minute
  • PIO2 – Partial pressure of inspired oxygen, mmHg
  • PETO2 – End-tidal oxygen partial pressure, mmHg
  • PETCO2 – End-tidal carbon dioxide partial pressure, mmHg
  • Respiratory Rate (RR) – The number of patient breaths per unit time
  • gPaO2™ – Calculated arterial partial pressure of oxygen, mmHg
  • Oxygen Deficit – Breath-based index of gas exchange inefficiency that is the difference between alveolar and arterial oxygen levels, mmHg
  • gPaO2/PAO2 – Arterial to alveolar partial pressure oxygen exchange ratio (Exchange efficiency), dimensionless
  • gPaO2/FiO2 – Ratio of arterial partial pressure of Oxygen to fraction of oxygen inspired
  • Respiratory Quotient (RQ) – The ratio between the amount of carbon dioxide (CO2) produced in metabolism and oxygen (O2) used, dimensionless

Product page: MediPines Gas Exchange Monitor…

Via: MediPines…